http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011172161-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d592f75ba75d574e4515fb89be3f113b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-59
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate 2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f630ebfdf34f690c53d8c2dff290e8de
publicationDate 2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011172161-A1
titleOfInvention Composition for therapeutic and cosmetic botulinum toxin
abstract This invention relates to a composition of botulinum based pharmaceuticals used for therapeutic and cosmetic treatment. This invention offers an improvement on the prior art by eliminating the potential of blood-borne contamination with botulinum based pharmaceuticals. Recombinant serum albumin is taught for use in the place of human serum albumin as a stabilizing or enhancing agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021050558-A1
priorityDate 2002-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7459164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7491403-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID207845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128122417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605

Total number of triples: 33.